Abstract
Purpose
To retrospectively analyze the concordance of bacterial culture between bone tissue and deep soft tissue in diabetic foot osteomyelitis (DFO) patients and clinical characteristics of patients.
Methods
This study collected samples from 155 patients with suspected DFO (who required amputation after clinical evaluation). Bacterial culture and drug susceptibility tests were performed on the patients’ deep soft tissue and bone tissue, and the consistency between the two was compared. In addition, the differences among DFO patients with different degrees of infection were compared classified by the PEDIS classifications.
Results
Among the 155 patients diagnosed with DFO, the positive rate of bone culture was 78.7% (122/155). This study cultured 162 strains, including 73 Gram-positive bacteria, 83 Gram-negative bacteria, and 6 fungi. Staphylococcus aureus (33 strains) was the most common bacteria. The overall agreement between bone culture and tissue culture was 42.8%, with Staphylococcus aureus and Enterobacteria having the best (64.3%) and least agreements (27.3%), respectively. The drug sensitivity results in bone culture showed that Staphylococcus aureus was the main Gram-positive bacteria. The bacteria were sensitive to linezolid and vancomycin. Proteus mirabilis was the main Gram-negative bacteria. These were more sensitive than biapenem and piperacillin/tazobactam. Fungi were more sensitive to voriconazole and itraconazole.
Conclusion
The culture results of deep soft tissues near the bone cannot accurately represent the true pathogen of DFO. For DFO patients, bone culture should be taken as much as possible, and appropriate antibiotics should be selected according to the drug susceptibility results.
Similar content being viewed by others
Data availability
The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding author.
References
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.
Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18–25.
Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288–93.
Aragón-Sánchez J, Lipsky BA. Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches. Expert Rev Anti Infect Ther. 2018;16(1):35–50.
Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1): e3280.
Meyr AJ, Seo K, Khurana JS, Choksi R, Chakraborty B. Level of agreement with a multi-test approach to the diagnosis of diabetic foot osteomyelitis. J Foot Ankle Surg. 2018;57(6):1137–9.
Elamurugan TP, Jagdish S, Kate V, Chandra PS. Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis. Int J Surg. 2011;9(3):214–6.
Ertugrul MB, Baktiroglu S, Salman S, Unal S, Aksoy M, Berberoglu K, et al. Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. J Am Podiatr Med Assoc. 2008;98(4):290–5.
Li X, Cheng Q, Du Z, Zhu S, Cheng C. Microbiological concordance in the management of diabetic foot ulcer infections with osteomyelitis, on the basis of cultures of different specimens at a diabetic foot center in China. Diabetes Metab Syndr Obes. 2021;14:1493–503.
Hockney SM, Steker D, Bhasin A, Krueger KM, Williams J, Galvin S. Role of bone biopsy and deep tissue culture for antibiotic stewardship in diabetic foot osteomyelitis. J Antimicrob Chemother. 2022;77(12):3482–6.
Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):45–74.
Weledji EP, Fokam P. Treatment of the diabetic foot–to amputate or not? BMC Surg. 2014;14:83.
Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis. 2006;42(1):57–62.
Manas AB, Taori S, Ahluwalia R, Slim H, Manu C, Rashid H, et al. Admission time deep swab specimens compared with surgical bone sampling in hospitalized individuals with diabetic foot osteomyelitis and soft tissue infection. Int J Low Extrem Wounds. 2021;20(4):300–8.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–93.
Afonso AC, Oliveira D, Saavedra MJ, Borges A, Simões M. Biofilms in diabetic foot ulcers: impact, risk factors and control strategies. Int J Mol Sci. 2021;22(15):8278.
Zenelaj B, Bouvet C, Lipsky BA, Uçkay I. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens? Int J Low Extrem Wounds. 2014;13(4):263–72.
Akinci B, Yener S, Yesil S, Yapar N, Kucukyavas Y, Bayraktar F. Acute phase reactants predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc. 2011;101(1):1–6.
Yusof NM, Rahman JA, Zulkifly AH, Che-Ahmad A, Khalid KA, Sulong AF, et al. Predictors of major lower limb amputation among type II diabetic patients admitted for diabetic foot problems. Singapore Med J. 2015;56(11):626–31.
Lin C, Liu J, Sun H. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a meta-analysis. PLoS ONE. 2020;15(9): e0239236.
Barshes NR, Mindru C, Ashong C, Rodriguez-Barradas M, Trautner BW. Treatment failure and leg amputation among patients with foot osteomyelitis. Int J Low Extrem Wounds. 2016;15(4):303–12.
Acknowledgements
The authors wish to thank the study participants for their cooperation and participation.
Funding
Henan Provincial People’s Hospital 23456 Talent Project (ZC23456081).
Author information
Authors and Affiliations
Contributions
HZ, conceptualization. JL and ZC, visualization. HZ, funding acquisition. JL, formal analysis. LL and YL, resources. JL, writing–original draft preparation. JL, ZC, writing–review and editing. HZ, supervision. All authors contributed to the article and approved the submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Henan Provincial People’s Hospital (2022–33), and all patients signed informed consent.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, J., Liu, L., Li, Y. et al. Concordance of bone culture and deep tissue culture during the operation of diabetic foot osteomyelitis and clinical characteristics of patients. Eur J Trauma Emerg Surg 49, 2579–2588 (2023). https://doi.org/10.1007/s00068-023-02342-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-023-02342-5